Cells were fixed with 4% PFA for 30 minutes, and intracellular glycogen was stained according to the manufacturers instructions
Nails in systemic disease
Organic salts may be derived from an organic acid such as, but not limited to, 1-hydroxy-2-naphthoic acid, 2,2-dichloroacetic acid, 2-hydroxyethanesulfonic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, 4- aminosalicylic acid, acetic acid, adipic acid, ascorbic acid, aspartic acid, benzenesulfonic acid, benzoic acid, camphoric acid, camphor-10-sulfonic acid, capric acid (decanoic acid), caproic acid (hexanoic acid), caprylic acid (octanoic acid), carbonic acid, cinnamic acid, citric acid, cyclamic acid, dodecylsulfuric organic acid such as, but not limited to, 1-hydroxy-2-naph the pharmaceutical formulation may include one or more salts at a concentration of from about 0.0001% (w/w) to about 0.001% (w/w), from about 0.001% (w/w) to about 0.01% (w/w), from about 0.01 % (w/w) to about 0.1 % (w/w), from about 0.1% (w/w) to about 1% (w/w), from about 0.1 % (w/w) to about 10% (w/w), from about 0.5% (w/w) to about 5% (w/w), from about 1% (w/w) to about 10% (w/w), from about 2% (w/w) to about 20% (w/w)from about 5% (w/w) to about 15% (w/w), from about 10% (w/w) to about 30% (w/w), from about 10% (w/w) to about 40% (w/w), from about 15% (w/w) to about 45% (w/w), from about 20% (w/w) to about 55% (w/w), from the pharmaceutical formulation may include one or more salts at concentrations such as, but not limited to, 2 % (w/w), 3% (w/w), 4% (w/w), 5% (w/w), 6% (w/w), 7% (w/w), 8% (w/w), 9% (w/w), 10% (w/w), 11% (w/w), 12 % (w/w), 13 % (w/w), 14% (w/w), 15 % (w/w), 16% (w/w), 17 % (w/w), 18% (w/w), 19% (w/w), and/or 20% (w/w)
Microbiol 4 , 623632 (2019)
